Project Grant R61MH139596
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a $1.92 million Project Grant to the University of California, Los Angeles (UCLA) under the Mental Health Research Grants program (CFDA 93.242) on September 18, 2025, with completion targeted for August 31, 2030. The Coaching and Leadership in Autism Support Settings (CLASS) study will conduct a cluster-randomized, hybrid effectiveness-implementation trial to test the clinical effectiveness of the Research Units...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $863,276 to the University of California, San Francisco on February 3, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a randomized controlled trial examining the effectiveness of the Resilience in Action (RIA) curriculum for young adults with autism spectrum disorder (YAASD). The research project, which extends through November 30, 2030, will expand testing of the RIA...
- Federal Grant Award Summary Massachusetts General Hospital's Research Management Division received a $129,290 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) on August 22, 2025. The award supports a two-year research initiative (through July 31, 2027) examining the relationship between genetic variation and developmental trajectories across autism spectrum disorder (ASD) and schizophrenia (SCZ). The research...
- Federal Grant Award Summary Children's Hospital Los Angeles received a $769,500 Project Grant from the National Institute of Mental Health under the Mental Health Research Grants program (CFDA 93.242) awarded on March 15, 2026, with a completion date of March 14, 2029. The grant supports the development and evaluation of Cognitive Behavioral Therapy for Depression in Autistic Youth (CBT-DAY), an autism-adapted evidence-based treatment intervention designed to address the substantial gap in...
- Federal Grant Award Summary Emory University received a $713,195 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective August 1, 2025 through July 31, 2028. The award supports an implementation pilot study for Function-Based Elopement Treatment (FBET), a parent-mediated intervention designed to address elopement—a prevalent and dangerous behavior in children with Autism Spectrum Disorder (ASD). The project...
- Federal Grant Award Summary The National Institute of Mental Health awarded a $1.46 million Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Massachusetts General Hospital effective September 15, 2025, through September 14, 2027. The award supports research on "Effect of Network-Based Real Time Neurofeedback Augmentation of Mindfulness Practice on Recurrent Negative Thinking in Adolescents at Risk for Serious Mental Illness." MGH will develop and...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded $762,566 to the University of Maryland, Baltimore on April 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct comprehensive multi-omic and synaptic imaging studies of the cerebellum in autism spectrum disorders (ASDs). The project, extending through December 31, 2030, will generate single-nuclei multi-omic profiles examining gene expression and chromatin accessibility...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $844,917 under the Mental Health Research Grants program (CFDA 93.242), effective July 1, 2025, through April 30, 2030. The project, titled "Moderate Effect Size Genes in Autism Spectrum Disorder," delivers research services focused on identifying and characterizing moderate effect size (MES) risk genes that contribute to autism spectrum...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a Project Grant totaling $196,597.00 under the Mental Health Research Grants program (CFDA 93.242) to The Regents of the University of California, San Francisco, effective July 1, 2025, through June 30, 2029. This four-year research initiative investigates the neurobiological mechanisms underlying autism spectrum disorder (ASD) phenotypes, specifically examining how a high-risk ASD gene mutation produces...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded University of Colorado-Denver $429,000 under the Mental Health Research Grants program (CFDA 93.242) for a two-year exploratory research project spanning June 1, 2025 through May 31, 2027. The project, titled "A Synaptogenic Adhesion Code for Myelin Specificity," investigates the molecular mechanisms underlying myelin formation and white matter abnormalities associated with autism spectrum disorder (ASD)...
The National Institute of Mental Health (NIMH) awarded $990,550 to Boston Children's Hospital under the Mental Health Research Grants program (CFDA 93.242) on March 10, 2026, for a research project titled "Developing Cognitive Control and Metacognition to Reduce the Functional Impact of Restricted and Repetitive Behaviors in Autism." This R61/R33 phased project grant will develop and test computer-based cognitive control training combined with metacognition coaching delivered by in-person coaches to school-aged children with autism spectrum disorder (ASD). The research will employ electroencephalographic (EEG) biomarkers to measure changes in neural responses associated with cognitive control, specifically the N2 event-related potential amplitude, as a mechanism through which the intervention reduces restricted and repetitive behaviors and interests. The two-phase research design includes an R61 exploratory phase enrolling 95 autistic children ages 8-11 years, with randomization to either the cognitive control training plus metacognition coaching intervention or a waitlist control group. Pending positive R61 outcomes, the R33 expansion phase will enroll 140 children to compare the cognitive control training intervention against an alternative educational game comparison condition. The project will conclude by February 29, 2028, and is expected to advance understanding of neurocognitive mechanisms underlying repetitive behaviors in autism while providing evidence for an innovative, scalable intervention approach for this core feature of ASD.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $990.6k | 3/9/26 |